Kalon Acquisition Corp's stock remains unchanged this week amid notable developments.
Kalon Acquisition Corp (KAC-P.V) has seen no price movement in the past week, maintaining its trading position at C$0.02. With no major company news to report, investors might be reflecting on recent events surrounding the company's proposed business combination with Pharmachal Health Group.
Advertisement
Kalon Acquisition Corp
KAC-P.V
KAC-P.V
Kalon Acquisition Corp
WealthAwesomeMarket cap
$215,600
52W high
$0.02
52W low
$0.02
1W change
+0.00%
Beta
-0.20
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KAC-P's historical volatility
30-Day Vol
0.0%
Annualized
90-Day Vol
0.0%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.02 – C$0.02 |
| 60 trading days | C$0.02 | C$0.02 – C$0.02 |
| 90 trading days | C$0.02 | C$0.02 – C$0.02 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Kalon Acquisition Corp's recent termination of its acquisition agreement with Pharmachal has left investors cautious, especially given the company's ongoing financial challenges. The lack of price movement signals a wait-and-see approach from shareholders.
Kalon Acquisition Corp's market cap stands at C$215,600.
With a profit margin of 0.0% and a negative return on equity of -33.8%, Kalon faces significant financial hurdles.
Bull case
There is potential for growth if Kalon can secure a more viable partnership or business model. Future business combinations and successful trials could pave the way for improvement in its market position.
Bear case
The termination of the agreement with Pharmachal raises concerns about Kalon’s strategy. The company's ongoing losses and negative return on equity indicate significant risks ahead, leaving investors wary of the future.
Recent Company News
Advertisement
Kalon Acquisition Corp has faced significant developments recently. On July 17, 2024, the company announced the termination of its share exchange agreement with Pharmachal Health Group Pty. Ltd. This decision came with no funds advanced and no contingent liabilities assumed, raising questions about Kalon's strategic direction. Earlier, on December 21, 2023, Kalon had entered into a definitive agreement with Pharmachal, indicating a potential shift in its business model. Investors are now left to consider the implications of this termination and what it means for future growth.
Technical Picture
Kalon Acquisition Corp's stock is currently trading at C$0.02, which aligns with both its 50-day and 200-day moving averages, indicating a lack of volatility in recent trading sessions. The stock has a beta of -0.20, suggesting it is less volatile than the broader market. With a 52-week range of C$0.02, the stock has remained stagnant, reflecting investor uncertainty. The trading volume has also been low compared to the average, further indicating a lack of interest or movement in the stock.
Financial Overview
As of the latest reports, Kalon Acquisition Corp holds a market capitalization of approximately C$215,600, with a profit margin of 0.0% and a return on equity of -33.8%. The company reported a net loss of CAD 0.012 million for the third quarter and CAD 0.043 million for the nine months ending April 30, 2024. These figures underscore the financial challenges Kalon faces as it navigates through its strategic decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
